Kraig Biocraft Laboratories (KBLB) Return on Capital Employed (2011 - 2025)

Kraig Biocraft Laboratories has disclosed Return on Capital Employed across 13 years of filings, most recently posting 9.53% for Q4 2025.

• Return on Capital Employed for Q4 2025 came in at 9.53%, down 2964.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 9.53% (down 2964.0% YoY), and the FY2025 annual result was 9.05%, down 3339.0% from the prior year.
• Return on Capital Employed came in at 9.53% for Q4 2025 at Kraig Biocraft Laboratories, down from 41.02% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 64.45% in Q4 2022 to a low of 19.22% in Q1 2021.
• The 5-year median for Return on Capital Employed is 44.79% (2023), against an average of 36.79%.
• Across the five-year window, Return on Capital Employed sank 7886 bps in 2021 and jumped 7716 bps in 2022, its largest moves.
• Kraig Biocraft Laboratories' Return on Capital Employed stood at 55.36% in 2021, then gained by 16 bps to 64.45% in 2022, then decreased by 26 bps to 47.93% in 2023, then declined by 18 bps to 39.17% in 2024, then plunged by 76 bps to 9.53% in 2025.
• The last three Return on Capital Employed figures came in at 9.53% (Q4 2025), 41.02% (Q3 2025), and 27.49% (Q2 2025), per Business Quant data.